RYTM (Rhythm Pharmaceuticals) Inventories, Other: $0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RYTM Rhythm Pharmaceuticals Inc RYTM
57 GF Score
Price $102.10
GF Value $113.70
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Rhythm Pharmaceuticals Inventories, Other?

Rhythm Pharmaceuticals RYTM -0.59% 57 Inventories, Other is $0.0 Mil as of Mar. 2026. GuruFocus rates RYTM with a GF Score™ of 57/100 and a GF Value™ of $113.70 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Rhythm Pharmaceuticals's other inventories for the quarter that ended in Mar. 2026 was $0.0 Mil.

Rhythm Pharmaceuticals's quarterly other inventories stayed the same from Sep. 2025 ($0.0 Mil) to Dec. 2025 ($0.0 Mil) but then increased from Dec. 2025 ($0.0 Mil) to Mar. 2026 ($0.0 Mil).

Rhythm Pharmaceuticals Inventories, Other Historical Data

* Premium members only.

The historical data trend for Rhythm Pharmaceuticals's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhythm Pharmaceuticals Inventories, Other Chart

Rhythm Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Rhythm Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RYTM
57GF Score
Rhythm Pharmaceuticals Inc RYTM
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhythm Pharmaceuticals Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of $0.0 Mil mean?
Rhythm Pharmaceuticals (RYTM) has a Inventories, Other of $0.0 Mil as of Mar. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Rhythm Pharmaceuticals and its competitors.
Is Rhythm Pharmaceuticals' Inventories, Other too high?
Rhythm Pharmaceuticals' current Inventories, Other is $0.0 Mil. Overall, Rhythm Pharmaceuticals has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rhythm Pharmaceuticals' Inventories, Other compare to MIRM and SYRE?
Rhythm Pharmaceuticals' Inventories, Other of $0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Biotechnology company?
A good Inventories, Other depends on the Biotechnology industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Rhythm Pharmaceuticals and its competitors. Rhythm Pharmaceuticals's current Inventories, Other is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhythm Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Rhythm Pharmaceuticals (RYTM) is currently considered Modestly Undervalued. The stock's GF Value™ is $113.70, compared to a current price of $102.10 — trading 10.2% below its estimated fair value. The current Inventories, Other is $0.0 Mil. Rhythm Pharmaceuticals' overall GF Score™ is 57/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Rhythm Pharmaceuticals (RYTM), the current Inventories, Other is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhythm Pharmaceuticals (RYTM) Overvalued in 2026?

Based on GuruFocus' analysis, Rhythm Pharmaceuticals stock appears to be undervalued. The current stock price of $102.10 is trading 10.2% below its estimated GF Value™ of $113.70. GuruFocus considers Rhythm Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for RYTM:

  • Inventories, Other: $0.0 Mil
  • GF Value™: $113.70 vs. price of $102.10 (10.2% below fair value)
  • GF Score™: 57/100 with 1 warning sign

No single metric tells the full story. See the RYTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rhythm Pharmaceuticals Business Description

Other Exchanges 1RV:Germany
Address 222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
57GF Score

Get the complete analysis for RYTM

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$102.10
Price
$113.70
GF Value